A randomized phase 3 trial of paclitaxel (P) plus carboplatin (C) versus paclitaxel plus ifosfamide (I) in chemotherapy-naive patients with stage I-IV, persistent or recurrent carcinosarcoma of the uterus or ovary: An NRG Oncology trial.
暂无分享,去创建一个
W. Richards | D. Mutch | A. Secord | D. Miller | A. Santin | M. Hensley | O. Ioffe | M. Powell | V. Filiaci | N. Spirtos | K. Tewari | L. Copeland | Helen Q. Huang | D. Warshal | K. Moore | Paul Disilverstro | D. Miller